|
Atomistry » Fluorine » PDB 8gkz-8hf8 » 8he7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 8gkz-8hf8 » 8he7 » |
Fluorine in PDB 8he7: Adp-Ribosyltransferase 1 (PARP1) Catalytic Domain Bound to A Quinazoline-2,4(1H,3H)-Dione InhibitorProtein crystallography data
The structure of Adp-Ribosyltransferase 1 (PARP1) Catalytic Domain Bound to A Quinazoline-2,4(1H,3H)-Dione Inhibitor, PDB code: 8he7
was solved by
X.Y.Wang,
J.Zhou,
B.L.Xu,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Adp-Ribosyltransferase 1 (PARP1) Catalytic Domain Bound to A Quinazoline-2,4(1H,3H)-Dione Inhibitor
(pdb code 8he7). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Adp-Ribosyltransferase 1 (PARP1) Catalytic Domain Bound to A Quinazoline-2,4(1H,3H)-Dione Inhibitor, PDB code: 8he7: Jump to Fluorine binding site number: 1; 2; Fluorine binding site 1 out of 2 in 8he7Go back to![]() ![]()
Fluorine binding site 1 out
of 2 in the Adp-Ribosyltransferase 1 (PARP1) Catalytic Domain Bound to A Quinazoline-2,4(1H,3H)-Dione Inhibitor
![]() Mono view ![]() Stereo pair view
Fluorine binding site 2 out of 2 in 8he7Go back to![]() ![]()
Fluorine binding site 2 out
of 2 in the Adp-Ribosyltransferase 1 (PARP1) Catalytic Domain Bound to A Quinazoline-2,4(1H,3H)-Dione Inhibitor
![]() Mono view ![]() Stereo pair view
Reference:
J.Zhou,
T.Du,
X.Wang,
H.Yao,
J.Deng,
Y.Li,
X.Chen,
L.Sheng,
M.Ji,
B.Xu.
Discovery of Quinazoline-2,4(1 H ,3 H )-Dione Derivatives Containing A Piperizinone Moiety As Potent Parp-1/2 Inhibitors─Design, Synthesis, in Vivo Antitumor Activity, and X-Ray Crystal Structure Analysis. J.Med.Chem. V. 66 14095 2023.
Page generated: Wed Jul 16 05:13:27 2025
ISSN: ISSN 0022-2623 PubMed: 37843892 DOI: 10.1021/ACS.JMEDCHEM.3C01152 |
Last articlesMn in 1IPSMn in 1IMD Mn in 1IR6 Mn in 1INO Mn in 1ID3 Mn in 1IMC Mn in 1ILX Mn in 1II7 Mn in 1HTO Mn in 1IGV |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |